CYDAN II, INC.

Profile

Company Names

CYDAN II, INC.

Addresses

700 TECHNOLOGY SQUARE, 3RD FLOOR, CAMBRIDGE, MA 02139

Phone Numbers

617-231-6020

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$10,666,666.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2017-09-28 
$10,666,666.00 
$34,000,000.00 
$23,333,334.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CHRISTOPH 
M. 
ADAMS 
EXECUTIVE OFFICER, DIRECTOR
CYDAN, LLC   |  IMARA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
SANDIP 
 
AGARWALA 
DIRECTOR
CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.   |  TALARIS THERAPEUTICS, INC.
METTE 
KIRSTINE 
AGGER 
DIRECTOR
ALLOCURE INC   |  SCPHARMACEUTICALS INC.   |  IMARA INC.   |  TREVI THERAPEUTICS, INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
BARBARA 
 
DALTON 
DIRECTOR
CELLADON CORP   |  CYDAN, LLC   |  LODO THERAPEUTICS CORP   |  PETRA PHARMA CORP   |  IMARA INC.   |  MORPHIC HOLDING, LLC   |  COMPLEXA INC.   |  CYDAN II, INC.   |  MAGNOLIA NEUROSCIENCES CORP
JAMES 
 
MCARTHUR 
EXECUTIVE OFFICER
CYDAN, LLC   |  CYDAN II, INC.   |  AGM CAPITAL FUND II, LLC   |  PEPGEN INC.
DAVID 
 
MOTT 
DIRECTOR
3-V BIOSCIENCES, INC.   |  TESARO, INC.   |  ARDELYX, INC.   |  ZYNGENIA, INC.   |  OMTHERA PHARMACEUTICALS, INC.   |  MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  EDIMER PHARMACEUTICALS, INC.   |  PROSENSA HOLDING N.V.   |  ADAPTIMMUNE LTD   |  MERSANA THERAPEUTICS, INC.   |  XTUIT PHARMACEUTICALS, INC.   |  IMARA INC.   |  COMPLEXA INC.   |  CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.
SARA 
 
NAYEEM 
DIRECTOR
MERSANA THERAPEUTICS INC   |  CYDAN, LLC   |  MERSANA THERAPEUTICS, INC.   |  IMARA INC.   |  CYDAN II, INC.   |  CENTREXION THERAPEUTICS CORP   |  TIBURIO THERAPEUTICS INC.   |  VANQUA BIO, INC.   |  NORMUNITY HOLDING COMPANY, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2017-10-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-28 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#